Symrise divests AmeriTerpenes to Mutares
The signing and closing occurred simultaneously, and both parties have agreed to keep financial details confidential.
GERMANY – Symrise AG has entered into a binding agreement to divest its AmeriTerpenes LLC terpene ingredients unit to Mutares SE & Co. KGaA, an international private equity firm.
This move is a strategic step intended to streamline Symrise’s portfolio and concentrate management attention on its core growth engines as part of the “ONE Symrise” strategy.
The transaction, which closed simultaneously with signing, positions AmeriTerpenes for long-term development under focused ownership while securing a long-term supply and commercial partnership between Symrise and the newly independent terpene business.
Symrise frames the divestment as active portfolio management that advances its ONE Symrise strategy by concentrating resources and leadership attention on core growth platforms while delivering sustainable profitable growth, operational excellence, and disciplined capital allocation.
For AmeriTerpenes, the sale to Mutares is presented as a path to continued investment and development of its renewable terpene ingredient portfolio for fragrance, flavor, and industrial applications under an owner experienced in corporate carve-outs.
According to Symrise, the operational carve-out has been successfully completed in recent months, positioning the business to continue developing under new ownership.
Symrise CEO Dr. Jean-Yves Parisot said the transaction exemplifies how the company is actively shaping its future through continued portfolio management, noting AmeriTerpenes’ strong people, longstanding customer relationships, and differentiated manufacturing capabilities.
He added that Mutares brings a strong operational track record in corporate carve-outs and is well-suited to support AmeriTerpenes’ future, and that Symrise looks forward to continuing its partnership with the business and Mutares through strategic agreements tied to the deal.
Both companies emphasize a seamless transition, with commitments to maintain business continuity, customer service excellence, and strong relationships with customers and suppliers.
Following closing, Symrise and AmeriTerpenes will continue their long-standing commercial relationship, with agreed supply arrangements that secure long-term access to renewable, terpene-based raw materials and create an enduring industrial partnership supporting both companies’ growth plans.
Symrise expects the transaction to result in a non-cash disposal loss in the mid–double-digit million-euro range, which will be reflected in its 2026 annual financial statements.
AmeriTerpenes is described as a leading producer of renewable terpene ingredients, serving customers across fragrance, flavour, and industrial applications from U.S. manufacturing sites in Jacksonville, Florida, and Colonels Island, Georgia.
Terpene ingredients are highlighted as key components in formulations where customers seek renewable, consistent, and high-performing solutions, underlining the strategic relevance of the business even as it moves outside Symrise’s core.
Symrise was advised by Stifel as financial adviser, Alvarez & Marsal as carve-out and vendor due diligence adviser, and Troutman Pepper Locke as legal adviser.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.
